Skip to main content
Gene Therapy Net RSS feed Follow Gene Therapy Net on Twitter LinkedIn - Gene Therapy Net discussion group Facebook - Gene Therapy Net

Newsletter April 2021

News: New approach to CAR T gene therapy yields efficient and longer-lasting response against HIV
A UCLA research team has shown that using a truncated form of the CD4 molecule as part of a gene therapy to combat HIV yielded superior and longer-lasting results in mouse models than previous similar therapies using the CD4 molecule. This new approach to CAR T gene therapy -- a type of immunotherapy that involves genetically engineering the body's own blood-forming stem cells to create HIV-fighting T cells -- has the potential to not only destroy HIV-infected cells but to create "memory cells" that could provide lifelong protection from infection with the virus that causes AIDS.

Company: Cytologics
Provider of human immune cells supporting biopharma companies and research organizations in early-stage discovery of therapies, clinical trials, quality control, manufacturing and commercialization. Our products range from HLA-typed PBMCs to specialty blood products to support biomedical research.
Visit Cytologics...

Conference: Gene Therapy Europe: Online
Driven by current industry focus, our congress encompasses presentations on advanced analytical strategies and next-gen technologies to progress gene therapy development from discovery to clinical stages. The event is free to attend for academic and industry institutions in order to help researchers share knowledge and network around key areas within the industry:, 5–6 May 2021.
Designed to deliver a forward-thinking perspective on the opportunities and challenges impacting market growth for this industry, our discovery stream addresses methods to overcome delivery and dosage challenges for gene therapy, alongside technical development of viral vector-based gene therapies.
The congress will also explore methods to accelerate drug development through translational gene therapy, with presentations focussing on modelling, prediction of response, biomarkers and surrogate endpoints.

Register now...

Conference: The 2nd Manufacturing Assets & Facility Management in Pharma Summit - Gene Therapy
‘As the world of cell and gene therapies continuously grows and progresses, the demand for reliable, next-gen bio-manufacturing facilities has grown along with it. The 2nd Manufacturing Assets & Facility Management in Pharma Summit is returning this 11-13 May 2021 to: explore best-in-class asset maintenance strategies; discuss the lessons learned when implementing predictive maintenance; and understand how to achieve 100% reliability, quality drugs and operational excellence.
With 21+ industry expert speakers, 2 deep dive workshops and 2 days of sessions including panels, roundtables and networking opportunities, this is your must-attend event to ensure your next-gen facility can meet the high demands of cell and gene therapy production.
Join us this May to delve into achieving sustainability goals, discuss flexibility and how to prepare your facility for an evolving pipeline, and hear the pain points and lessons learned when implementing smart manufacturing solutions. This is your opportunity to meet and learn from your peers at Sanofi, FUJIFILM Diosynth, Novartis, Seattle Genetics, AstraZeneca, Merck, MSD Biologics and more!

Register now...

Conference: 5th Annual MarketsandMarkets Bioprocessing of Biotherapeutics
After the successful foureditions of Bioprocessing of Cell therapies, coming up with 5th Annual of Bioprocessing of Biotherapeutics, 20-21 May 2021, brings together leading bioprocessing scientists to share day-to-day challenges and practical solutions for the development, manufacture and quality of protein expressions, cell, and gene therapies.
The virtual event will present detailed case studies and interactive discussions in cell culture, scale-up, continuous processing, recovery, purification, process and product characterization, and formulation.

Register now...

Conference: Inner Ear Disorders Therapeutics Summit
As the gene therapy field progresses, more and more disease indications can now be targeted using gene therapy, and inner ear disorders are no exception. The Inner Ear Disorders Therapeutics Summit, 25-27 May 2021, is gathering the world’s leading biopharmaceutical companies and KOLs at the only industry-focused summit dedicated to the translation and clinical development of novel gene therapy, cell therapy and small molecule-based approaches to treat inner ear disorders, with the aim to progress the industry towards the first clinically approved therapy.
Register now...

Conference: Next Generation Gene Therapy Vectors
With more clinical data accessible than ever before, the limitations of current gene therapy vector technology have never been so clear. This means the search is on for more targeted, specific, efficient, and ultimately safe vectors. The online inaugural Next Generation Gene Therapy Vectors meeting, 8-10 June 2021, is the only conference dedicated to overcoming the current toxicity, targeting, immunogenicity, and manufacturability challenges facing the field by pioneering the next generation of superior delivery vectors.
Register now...

Conference: 2nd RNAi- Based Therapeutics Summit
With 2021 set to be a landmark year for RNAi therapies, the RNAi-Based Therapeutics Summit, 15-17 June 2021, is a crucial industry touchpoint uniting academic KOLs & senior biopharmaceutical leaders from discovery, translation & clinical development functions to stay ahead of the race in developing the first targeted extrahepatic RNAi therapy that addresses unmet patient need.
Register now...

- 20 - 21 April 2021, Formulation & Delivery Europe: Gene and Cell Therapies, Online event
- 27 - 29 April 2021, Neuroimmunology Drug Development Summit, Online event
- 28 April 2021, World Orphan Drug Congress USA Virtual, Online event
- 5 - 6 May 2021, Cell Series UK 2021 - Gene Therapy Europe, Online event
- 11 - 13 May 2021, 2nd (Gene Therapy) Manufacturing Assets & Facility Management in Pharma (MAFM) Summit, Online event
- 11 - 14 May 2021, American Society of Gene and Cell Therapy (ASGCT) 24th Annual Meeting, Online event
- 18 - 20 May 2021, Genetic Vaccine Development for Infectious Diseases Summit, Online event
- 20 - 21 May 2021, 5th Annual MarketsandMarkets Bioprocessing of Biotherapeutics-UK,EU & APAC, Online event
- 25 - 27 May 2021, Inner Ear Disorders Therapeutics Summit - Gene Therapy Solutions, Online event
- 25 - 27 May 2021, Gene Therapy Analytical Development Europe, Online event
- 25 - 27 May 2021, Gene Therapy for Muscular Disorders, Online event
- 26 - 28 May 2021, International Society for Cell and Gene Therapy (ISCT) New Orleans virtual meeting, Online event
- 8 - 10 June 2021, Next Generation Gene Therapy Vectors, Online event
- 10 - 11 June 2021, MarketsandMarkets Cell & Gene Therapy Manufacturing Virtual Conference, Online event
- 15 - 17 June 2021, 2nd RNAi- Based Therapeutics Summit, Online event
- 28 - 30 June 2021, 3rd Annual Blood-Brain Barrier Summit - Exploring CNS Gene Therapy & New Generation Vectors, Online event
- 29 - 30 June 2021, Formulation & Delivery US: Gene and Cell Therapies, San Diego, CA
- 13 - 15 July 2021, Epigenetic Therapeutic Targets Summit, Online event
- 19 - 21 July 2021, 2nd Gene Therapy for Neurological Disorders Europe, Online event
- 27 - 29 July 2021, Gamma Delta T Therapies Summit, Online event
- 3 - 5 August 2021, 2nd Gene Therapy Immunogenicity Summit, Online event
- 16 - 19 August 2021, 13th Annual The Bioprocessing Summit, Boston, MA
- 25 - 27 August 2021, World Orphan Drug Congress USA, Maryland, USA
- 30 August - 2 September 2021, 6th CAR-TCR Summit, Online event
- 1 - 3 September 2021, World Smart Bioprocessing: Pharma 4.0 Summit, Berlin, Germany
- 21 - 22 September 2021, Formulation & Delivery UK: Gene and Cell Therapies, London, UK
- 22 - 23 September 2021, Oligonucleotide Therapeutics and Delivery conference, London, UK
- 12 - 13 October 2021, Pharma Europe 2021 - Cell & Gene Therapies, Barcelona, Spain
- 18 - 20 October 2021, Advancing Gene Therapy 2021, Boston, MA
- 19 - 21 October 2021, XXVIII Congress of the European Society of Gene and Cell Therapy (ESGCT), Brussels, Belgium
- 10 - 11 November 2021, Pharma Manufacturing: Gene and Cell Therapies, Online event
- 16 - 17 November 2021, Onco Cell Therapy Summit (OCTS) USA 2021, Boston, MA
- 22 - 23 November 2021, Ophthalmic Drugs Conference - Gene Therapies, London, UK


Gene Therapy Net is the information resource for basic and clinical research in gene therapy, and the site serves as a network in the exchange of gene therapy information and breaking news items. Visitors can keep track of the latest scientific papers, conference announcements, gene therapy jobs, regulations and guidelines. Other information websites created and maintained by the owner of Gene Therapy Net are Dengue Virus Net, Influenza Virus Net, Ebola Virus Net, Chikungunya Virus Net, Zika Virus Net and Corona Virus Net.
To unsubscribe from the Newsletter, please login and edit your subscription details, or {unsubscribe}unsubscribe direct{/unsubscribe}, or contact us. You are currently registered as: {subtag:name}, email address: {subtag:email}.

Advertise on this site?